Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07729462 A Study to Learn About the Study Medicine Called Rimegepant in Adults W… |
Rimegepant | Migraine | Phase 3 | RECRUITING | En attente / non publié | University of South Florida | United States, Israel · Austin Clinical Trial Partner… | 2026-08-26 → 2029-01-19 | Ouvrir |
| NCT07609914 A Study to Learn About the Safety of Taking an Additional Dose of the M… |
Rimegepant | Migraine | Phase 4 | RECRUITING | En attente / non publié | University of South Florida | United States, Israel · Alliance Clinical Research La… | 2026-05-28 → 2028-06-07 | Ouvrir |
| NCT05825274 TDCs to Treat Drug-resistant Epilepsy |
Active Cathodal tDCS | Épilepsie | Non applicable | COMPLETED | En attente / non publié | Spanish Foundation for Neurometri… | United Kingdom · Bigdata4brain LTD, Liverpool, United… | 2017-01-01 → 2017-12-28 | Ouvrir |
| NCT05076838 Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy |
Diazepam Nasal Spray [Valtoco] | Épilepsie | Phase 1/2 | COMPLETED | En attente / non publié | Neurelis, Inc. | United States · AdventHealth Research Institute, Orla… | 2021-11-08 → 2025-03-11 | Ouvrir |
| NCT06612775 A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 … |
Test drug CB03-154 5mg group | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Shanghai Zhimeng Biopharma, Inc. | Australia · Alfred Health, Melbourne, Australia | 2024-08-14 → 2027-11 | Ouvrir |
| NCT07835594 EpHR-DP — Studying Heart Rhythms With a Wearable Sensor to Detect and P… |
Textile-based wearable electrocar… | Épilepsie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Acibadem University | Turkey (Türkiye) · Sancaktepe Şehit Prof. Dr. İlhan V… | 2026-10-15 → 2028-10-15 | Ouvrir |
| NCT07599150 ICARE — Intracranial CArtography of Cortical Contribution to Respirator… |
SEEG monitoring | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Hospices Civils de Lyon | France · Service de Neurologie Fonctionne et d'Epilep… | 2026-09-17 → 2028-09-17 | Ouvrir |
| NCT07012148 FORESITE — Optimizing Therapy in Epilepsy Using Seizure Forecasts Via E… |
UNEEG SubQ device, seizure foreca… | Épilepsie | Phase 1 | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2026-01-20 → 2029-12 | Ouvrir |
| NCT03233399 Modulating Movement Intention Via Cortical Stimulation |
Sham TMS3 stimulation | Épilepsie | Non applicable | RECRUITING | En attente / non publié | NYU Langone Health | United States · New York University School of Medicin… | 2017-07-20 → 2027-05 | Ouvrir |
| NCT07563881 FOCUS 1 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult … |
RAP-219 | Épilepsie | Phase 3 | RECRUITING | En attente / non publié | Rapport Therapeutics Inc. | United States, South Korea · Amicis Research Center, … | 2026-06-05 → 2029-09 | Ouvrir |
| NCT07651319 Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease |
IL-2 (Aldesleukin) | Alzheimer | Phase 1/2 | RECRUITING | En attente / non publié | The Methodist Hospital Research I… | United States · Houston Methodist Research Institute,… | 2026-09-01 → 2029-12 | Ouvrir |
| NCT05667649 Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Dire… |
RB-ADSC | Alzheimer | Phase 1 | COMPLETED | En attente / non publié | Regeneration Biomedical, Inc. | United States · Hoag Memorial Hospital Presbyterian, … | 2023-08-14 → 2026-06-25 | Ouvrir |
| NCT07780383 A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, … |
BMS-986446 | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States · CenExel ACT (Formerly Anaheim Clinica… | 2026-08-21 → 2027-06-17 | Ouvrir |
| NCT07839650 AD_tACSrehab — Transcranial Alternating Current Stimulation (tACS) Comb… |
Transcranial Alternating Current … | Alzheimer | Non applicable | RECRUITING | En attente / non publié | IRCCS Centro San Giovanni di Dio … | Italy · IRCCS Istituto Centro San Giovanni Di Dio - F… | 2026-09-16 → 2032-09 | Ouvrir |
| NCT07838155 A Study of Donanemab (LY3002813) in Participants With Early Symptomatic… |
Donanemab | Alzheimer | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Eli Lilly and Company | India · Apollo Multispeciality Hospitals Limited, Kol… | 2026-10 → 2030-07 | Ouvrir |
| NCT06803823 A Study of ONO-2020 in Patients With Agitation Associated With Alzheime… |
ONO-2020 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Ono Pharmaceutical Co., Ltd. | Japan · Aburayama Hospital, Fukuoka, Japan | Airanomo… | 2025-05-01 → 2027-03-31 | Ouvrir |
| NCT07841808 Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System)… |
TMS-EEG | Alzheimer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Sinaptica Therapeutics, Inc. | Non communiqué | 2026-10 → 2027-04 | Ouvrir |
| NCT07827768 SAGITTARIUS — AV-1959R Vaccine in Individuals With Preclinical Alzheime… |
AV-1959R | Alzheimer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Institute for Molecular Medicine | Non communiqué | 2027-03-01 → 2029-06-15 | Ouvrir |
| NCT05888961 MAPEG 2 — Single-center Prospective Longitudinal Study of Taste in Pati… |
Blood samples | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Centre Hospitalier Universitaire … | France · CHU Dijon Bourgogne, Dijon, France | 2023-06-12 → 2027-12 | Ouvrir |
| NCT07169578 TRONTIER 1 — A Study of Trontinemab in Participants With Early Symptoma… |
Trontinemab | Alzheimer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Brazil, Canada, China, Fran… | 2025-09-17 → 2028-02-16 | Ouvrir |
| NCT07170150 TRONTIER 2 — A Clinical Trial of Trontinemab in Participants With Early… |
Trontinemab | Alzheimer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Brazil, Canada, … | 2025-11-12 → 2028-02-16 | Ouvrir |
| NCT00461942 Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Dise… |
Green Tea Polyphenols (EGCG/ECG) | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Xuanwu Hospital, Beijing | China · Beijing Institute of Geriatrics, Xuanwu Hospi… | 2006-04 → 2009-03 | Ouvrir |
| NCT07464028 TAME-PD: — Terazosin And Metabolic Energetics in Parkinson's Disease |
Terazosin 5 MG | Parkinson | Phase 2 | SUSPENDED | En attente / non publié | Nandakumar Narayanan | United States · University of Iowa, Iowa City, United… | 2028-07-01 → 2031-07-01 | Ouvrir |
| NCT07838636 EPA-DBS — Effect of Physical Activity on the Course of Parkinson's Dise… |
Physiotherapy | Parkinson | Non applicable | RECRUITING | En attente / non publié | Medical University of Warsaw | Poland · Department of Neurology, Faculty of Health S… | 2024-09-05 → 2028-09-05 | Ouvrir |
| NCT05152147 HERIZON-GEA-01 — A Study of Zanidatamab in Combination With Chemotherap… |
Zanidatamab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Jazz Pharmaceuticals | Argentina, Australia, Belgium, Brazil, Canada, Chile,… | 2021-12-02 → 2027-09-30 | Ouvrir |